Eunice S Wang Selected Research

IMC1C11

11/2004

Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eunice S Wang Research Topics

Disease

73	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 03/2009
34	Neoplasms (Cancer) 02/2024 - 06/2003
19	Leukemia 01/2022 - 05/2007
14	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2023 - 10/2010
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2024 - 08/2010
8	Lymphoma (Lymphomas) 01/2021 - 06/2003
6	Hematologic Neoplasms (Hematological Malignancy) 09/2020 - 07/2013
5	Disease Progression 05/2024 - 10/2010
5	Thrombocytopenia (Thrombopenia) 01/2023 - 10/2010
5	Hypoxia (Hypoxemia) 01/2021 - 10/2010
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 09/2008
3	Philadelphia Chromosome 05/2024 - 05/2007
3	Multiple Myeloma 03/2023 - 01/2004
3	Blast Crisis (Blast Phase) 01/2022 - 01/2018
3	Acute Promyelocytic Leukemia 01/2018 - 01/2014
2	Residual Neoplasm 05/2024 - 04/2018
2	Primary Myelofibrosis (Myelosclerosis) 01/2024 - 05/2011
2	Anemia 11/2023 - 07/2012
2	Febrile Neutropenia 01/2023 - 07/2012
2	Diarrhea 01/2023 - 01/2015
2	Neutropenia 01/2023 - 07/2012
2	Hypoalbuminemia 10/2022 - 01/2019
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 08/2022 - 11/2014
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 09/2012
2	Body Weight (Weight, Body) 01/2019 - 03/2012
2	Fatigue 01/2019 - 01/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2004 - 09/2003
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2004 - 01/2004
1	Splenomegaly 01/2024
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023
1	Fever (Fevers) 01/2023

Drug/Important Bio-Agent (IBA)

17	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2021 - 09/2003
8	Tyrosine Kinase InhibitorsIBA 05/2024 - 02/2011
6	Decitabine FDA Link 11/2023 - 06/2015
6	Gemtuzumab (Mylotarg)FDA Link 01/2023 - 10/2012
5	Imatinib Mesylate (Gleevec)FDA Link 05/2024 - 09/2008
5	Phosphotransferases (Kinase)IBA 01/2020 - 02/2011
4	fms-Like Tyrosine Kinase 3IBA 01/2023 - 01/2020
4	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 10/2010
4	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021 - 03/2013
4	AnthracyclinesIBA 01/2021 - 10/2010
4	Arsenic Trioxide (Trisenox)FDA Link 01/2018 - 11/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2013 - 11/2004
3	tagraxofuspIBA 02/2024 - 01/2019
3	Monoclonal AntibodiesIBA 11/2023 - 03/2009
3	gilteritinibIBA 01/2023 - 01/2019
3	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2017
3	Long Noncoding RNAIBA 01/2022 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2011
3	Dasatinib (BMS 354825)FDA Link 01/2020 - 05/2007
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2017
3	InterferonsIBA 01/2019 - 02/2011
3	AntigensIBA 04/2018 - 03/2016
3	Tyrosine (L-Tyrosine)FDA Link 06/2015 - 03/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2013 - 09/2003
3	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 03/2012 - 11/2011
3	Methotrexate (Mexate)FDA LinkGeneric 11/2004 - 06/2003
2	ruxolitinibIBA 01/2024 - 10/2020
2	magrolimabIBA 11/2023 - 01/2023
2	onvansertibIBA 11/2023 - 12/2020
2	EnzymesIBA 01/2023 - 01/2019
2	glasdegibIBA 08/2022 - 11/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
2	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 02/2011
2	Cladribine FDA LinkGeneric 01/2021 - 01/2015
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 01/2017
2	blinatumomabIBA 01/2018 - 06/2015
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018 - 01/2014
2	Lenalidomide (CC 5013)FDA Link 04/2016 - 11/2012
2	Bortezomib (Velcade)FDA Link 04/2016 - 03/2013
2	Rituximab (Mabthera)FDA Link 04/2016 - 11/2004
2	AntibodiesIBA 04/2016 - 11/2004
2	Vancomycin FDA LinkGeneric 04/2016 - 03/2012
2	Sorafenib (BAY 43-9006)FDA Link 06/2015 - 02/2011
2	Sunitinib (Sutent)FDA Link 11/2014 - 02/2011
2	Clofarabine (Clolar)FDA Link 11/2013 - 07/2012
2	afliberceptIBA 07/2013 - 10/2010
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2013 - 11/2011
2	romiplostim FDA Link 11/2012 - 10/2010
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2011 - 11/2004
1	ponatinibIBA 05/2024
1	FF-10101IBA 03/2024
1	parsaclisibIBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 11/2023
1	Chimeric Antigen ReceptorsIBA 03/2023
1	NK Cell Lectin-Like Receptor Subfamily KIBA 03/2023
1	LigandsIBA 03/2023
1	olutasidenibIBA 01/2023
1	CPX-351IBA 01/2023
1	Histone DemethylasesIBA 01/2023
1	Alanine (L-Alanine)FDA Link 10/2022

Therapy/Procedure

45	Therapeutics 03/2024 - 06/2003
21	Drug Therapy (Chemotherapy) 01/2023 - 09/2003
4	Cell Transplantation 01/2023 - 09/2014
4	Immunotherapy 04/2018 - 03/2009
3	Induction Chemotherapy 10/2022 - 07/2015
2	Transplantation 01/2023 - 01/2016
2	Hematopoietic Stem Cell Transplantation 10/2020 - 04/2016